Repurposing staples for viruses: applying peptide design to RSV prophylaxis.

Katen SP, Dermody TS
J Clin Invest. 2014 124 (5): 1889-91

PMID: 24743141 · PMCID: PMC4001561 · DOI:10.1172/JCI75797

Respiratory syncytial virus (RSV) is responsible for lower respiratory tract infections and annually results in 200,000 deaths worldwide. Despite the burden of RSV-associated disease, treatments and preventative measures are limited. In this issue of JCI, Bird and colleagues describe their work using a peptide stapling technique that allowed synthesis of a stable peptide mimic of a portion of the RSV fusion protein. Pretreatment of cells with the stable peptide effectively blocked virus entry. When introduced into mice prior to RSV exposure, the peptide produced a substantial prophylactic effect. This work provides a new way forward in RSV prevention.

MeSH Terms (8)

Animals Female Nose Diseases Peptides Pneumonia, Viral Respiratory Syncytial Viruses Respiratory Syncytial Virus Infections Viral Fusion Proteins

Connections (1)

This publication is referenced by other Labnodes entities: